|
시장보고서
상품코드
1863941
세계의 엑소좀 연구 시장 : 제품 유형별, 질병적응증별, 워크플로우별, 개발 단계별, 최종 사용자별, 지역별Exosome Research Market, By Product Type, By Disease Indication, By Workflow, By Development Stage, By End User, By Geography |
||||||
세계의 엑소좀 연구 시장은 2025년 2억 4,150만 달러로 추정되고, 2032년까지 7억 5,120만 달러에 이를 것으로 예측되고 있습니다. 2025년부터 2032년까지 CAGR 17.6%로 확대될 것으로 전망되고 있습니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 2억 4,150만 달러 |
| 실적 데이터: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간 중 CAGR: | 17.60% | 2032년 가치 예측 : | 7억 5,120만 달러 |
세계의 엑소좀 연구 시장은 생명공학 및 생명과학 산업에서 빠르게 진화하고 있는 분야이며, 세포간 커뮤니케이션에서 중요한 역할을 하는 나노스케일의 세포외 소포인 엑소좀의 조사와 응용에 초점을 맞추었습니다.
이러한 막 결합성 소포는 직경이 통상 30-150나노미터이며, 다양한 세포 유형에서 분비되어 단백질, 지질, 핵산 등 다양한 분자화물을 내포하고 있습니다. 엑소좀은 특히 종양학, 신경학, 재생 의료의 응용 분야에서 질병 진단의 중요한 바이오마커, 치료 표적, 약물 전달 수단으로서 대두해 왔습니다.
본 시장은 엑소좀 연구에 필수적인 조사 툴, 분리 및 정제 기술, 특성 평가 장치, 분석 서비스 등을 포함하고 있습니다. 엑소좀의 생물학적 특성과 정밀의료에 대한 가능성에 대한 이해가 깊어짐에 따라 제약기업, 학술기관, 바이오테크놀러지 기업으로부터 많은 투자가 모아지고 있습니다. 분리기술, 분석기법, 표준화 프로토콜에 있어서의 눈부신 기술적 진보가 시장 확대를 견인하고 있습니다.
주요 응용 분야는 바이오마커 발견, 치료법 개발, 진단 용도 및 특히 액체 생검 기술과 맞춤형 의료 접근법에 중점을 두고 있으며, 엑소좀 연구 시장은 차세대 생물의학 연구와 임상 응용의 기반으로 자리잡고 있습니다.
시장 역학
세계의 엑소좀 연구 시장은 현저한 성장 가능성과 연구 및 임상 응용 분야에서의 광범위한 보급을 뒷받침하는 몇 가지 강력한 촉진요인에 의해 견인되고 있습니다. 주요 촉진요인은 세계적으로 증가하는 암과 신경 질환의 유병률에 있습니다. 이로 인해 질병 특이적인 분자 시그니처와 저침습 감지 능력을 갖춘 엑소좀이 유망한 후보로 자리매김되어 새로운 진단 바이오마커 및 치료 접근법에 대한 수요가 증가하고 있습니다. 액체 생검 기술의 채용 확대도 중요한 촉진요인이며, 엑소좀은 기존의 조직 생검과 비교하여 간단한 채혈에 의한 실시간 질환 모니터링과 치료 효과 평가가 가능하다는 이점을 제공합니다.
게다가 제약기업과 학술기관에 의한 연구개발에 대한 엄청난 투자와 엑소좀 연구 이니셔티브에 대한 정부자금 증가가 함께 시장 성장을 가속화하고 있습니다. 그러나, 표준화된 분리 및 특성평가 프로토콜의 부족과 같은 현저한 제약도 존재하고, 연구 결과의 편차를 일으켜, 임상 응용에 있어서의 규제 당국의 승인을 방해하고 있습니다.
엑소좀 이질성, 낮은 수율 분리 기법, 분석 기술의 복잡성과 관련된 기술적 과제도 시장 확대의 장벽이 되고 있습니다. 또한 특수 장비 및 시약의 고비용, 최종 사용자의 엑소좀 응용에 대한 낮은 인지도도 시장 침투를 제한합니다. 이러한 과제가 있음에도 불구하고, 약물 전달 시스템에서 엑소좀의 응용 확대는 큰 기회를 낳고 있습니다. 천연 생체적합성과 표적화 능력은 합성 담체에 비해 우수한 치료 효과를 제공하기 때문입니다.
개인화된 의료 및 정밀 진단에 대한 관심 증가는 특히 질병의 조기 발견 및 예후 예측에서 엑소좀 기반 바이오마커 개발에 큰 기회를 만들어 냈습니다. 한편, 아시아태평양과 라틴아메리카의 신흥 시장에서는 의료투자 증가와 연구 인프라의 정비가 진행됨에 따라 시장 확대의 미개발 가능성이 확대되고 있습니다.
본 조사의 주요 특징
- 본 보고서는 세계 엑소좀 연구 시장에 대한 상세한 분석을 제공하며, 2024년을 기준연도로 예측기간 중(2025-2032년) 시장 규모 및 CAGR(%)을 나타냅니다.
- 또한 각 부문에서 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품의 발매 또는 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략에 관한 중요한 지견도 제공합니다.
- 이 설문 조사는 다음 매개 변수를 기반으로 세계 엑소좀 연구 시장의 주요 기업을 프로파일링합니다 : 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략
- 이 보고서의 발견은 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보를 기반으로 의사 결정을 내릴 수 있도록 합니다.
- 이 보고서는 세계 엑소좀 연구 시장에서 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 업계의 다양한 이해 관계자를 대상으로 합니다.
- 이해관계자는 세계의 엑소좀 연구시장 분석에 이용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 할 수 있게 됩니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 엑소좀 연구 시장 : 제품 유형별, 2020-2032년
- 소모품(키트, 시약, 컬럼, 비드, 카트리지)
- 기기(예: NTA 기기, 마이크로유체 디바이스, 웨스턴 블롯, ELISA 기기)
- 소프트웨어 및 서비스
제5장 세계의 엑소좀 연구 시장 : 용도별, 2020-2032년
- 진단(예: 암 바이오마커 검출, 신경질환 진단, 액체 생검)
- 치료제(예: 약물 전달 시스템, 재생 의료, 백신 개발)
- 연구 개발(기초 조사, 창약, 질환 메커니즘 연구)
제6장 세계의 엑소좀 연구 시장 : 질환 적응증별, 2020-2032년
- 종양학
- 신경학/신경변성
- 심혈관계
- 감염증
- 대사/내분비
- 자가면역/염증
- 생식/출생전
- 기타(예: 피부과, 안과)
제7장 세계의 엑소좀 연구 시장 : 워크플로우별, 2020-2032년
- 분리 방법
- 초원심 분리
- 침전법
- 면역친화성 포착
- 사이즈 기반 분리
- 마이크로플루이딕스 기술
- 다운스트림 분석
- 특성 평가(입자 사이즈, 농도, 표면 마커)
- 유동 세포 계측법을 이용한 세포 표면 마커 분석
- 블롯팅과 ELISA를 이용한 단백질 분석
- NGS와 PCR에 의한 RNA 분석
- 질량분석법을 이용한 프로테옴 해석
- 기타
제8장 세계의 엑소좀 연구 시장 : 개발 단계별, 2020-2032년
- 발견
- 전임상
- 임상 I
- 임상 II
- 임상 III
제9장 세계의 엑소좀 연구 시장 : 최종 사용자별, 2020-2032년
- 병원 및 임상 실험실
- 제약 및 바이오테크놀러지 기업
- 병원 및 진단센터
- 정부 및 비영리단체
- 학술연구기관
- 기타(CRO/CMO)
제10장 세계의 엑소좀 연구 시장 : 지역별, 2020-2032년, 가치
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Thermo Fisher Scientific
- Illumina Inc
- Miltenyi Biotec
- QIAGEN
- Exosome Diagnostics
- Lonza Group
- Sysmex Corporation
- StellaLife Inc
- Cell Guidance Systems
- Bio-Techne Corporation
- Nanosomix
- Roche
- Cytiva
- Nanovision Biosciences
- Luminex Corporation
제12장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
Exosome Research Market is estimated to be valued at USD 241.5 Mn in 2025 and is expected to reach USD 751.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 17.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 241.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 17.60% | 2032 Value Projection: | USD 751.2 Mn |
The global exosome research market represents a rapidly evolving sector within the biotechnology and life sciences industry, focusing on the study and application of exosomes - nanoscale extracellular vesicles that play crucial roles in intercellular communication.
These membrane-bound vesicles, typically ranging from 30-150 nanometers in diameter, are secreted by various cell types and contain diverse molecular cargo including proteins, lipids, and nucleic acids. Exosomes have emerged as significant biomarkers for disease diagnosis, therapeutic targets, and drug delivery vehicles, particularly in oncology, neurology, and regenerative medicine applications.
The market encompasses research tools, isolation and purification technologies, characterization instruments, and analytical services essential for exosome studies. Growing understanding of exosome biology and their potential in precision medicine has attracted substantial investment from pharmaceutical companies, academic institutions, and biotechnology firms. The field has witnessed remarkable technological advancements in isolation techniques, analytical methodologies, and standardization protocols, driving market expansion.
Key applications span across biomarker discovery, therapeutic development, and diagnostic applications, with particular emphasis on liquid biopsy technologies and personalized medicine approaches, positioning the exosome research market as a cornerstone of next-generation biomedical research and clinical applications.
Market Dynamics
The global exosome research market is propelled by several compelling drivers that underscore its significant growth potential and widespread adoption across research and clinical applications. The primary driver stems from the increasing prevalence of cancer and neurological disorders globally, which has intensified the demand for novel diagnostic biomarkers and therapeutic approaches, positioning exosomes as promising candidates due to their disease-specific molecular signatures and minimal invasive detection capabilities. The rising adoption of liquid biopsy technologies represents another crucial driver, as exosomes offer advantages over traditional tissue biopsies by providing real-time disease monitoring and treatment response assessment through simple blood draws.
Additionally, substantial investments in research and development by pharmaceutical companies and academic institutions, coupled with growing government funding for exosome research initiatives, have accelerated market growth. However, the market faces notable restraints including the lack of standardized isolation and characterization protocols, which creates variability in research outcomes and hinders regulatory approvals for clinical applications.
Technical challenges related to exosome heterogeneity, low yield isolation methods, and the complexity of analytical techniques pose additional barriers to market expansion. Furthermore, high costs associated with specialized equipment and reagents, along with limited awareness among end users about exosome applications, restrict market penetration. Despite these challenges, significant opportunities emerge from the expanding applications of exosomes in drug delivery systems, where their natural biocompatibility and targeting capabilities offer superior therapeutic outcomes compared to synthetic carriers.
The growing focus on personalized medicine and precision diagnostics creates substantial opportunities for exosome-based biomarker development, particularly in early disease detection and prognosis prediction, while emerging markets in Asia Pacific and Latin America present untapped potential for market expansion through increasing healthcare investments and research infrastructure development.
Key Features of the Study
- This report provides in-depth analysis of the global exosome research market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global exosome research market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Illumina Inc, Miltenyi Biotec, QIAGEN, Exosome Diagnostics, Lonza Group, Sysmex Corporation, StellaLife Inc, Cell Guidance Systems, Bio-Techne Corporation, Nanosomix, Roche, Cytiva, Nanovision Biosciences, and Luminex Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global exosome research market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosome research market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Consumables (kits, reagents, columns, beads, cartridges)
- Instruments (e.g., NTA devices, microfluidic devices, Western blot, ELISA instruments)
- Software and Services
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Diagnostics (e.g., cancer biomarker detection, neurological disease diagnostics, liquid biopsy)
- Therapeutics (e.g., drug delivery systems, regenerative medicine, vaccine development)
- Research and Development (basic research, drug discovery, disease mechanism studies)
- Disease Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Neurology/neurodegeneration
- Cardiovascular
- Infectious diseases
- Metabolic/endocrine
- Autoimmune/inflammation
- Reproductive/prenatal
- Others (e.g., dermatology, ophthalmology)
- Workflow Insights (Revenue, USD Mn, 2020 - 2032)
- Isolation Methods
- Ultracentrifugation
- Precipitation
- Immunoaffinity Capture
- Size-Based Isolation
- Microfluidic Techniques
- Downstream Analysis
- Characterization (Particle Size, Concentration, Surface Markers)
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
- Development Stage Insights (Revenue, USD Mn, 2020 - 2032)
- Discovery
- Preclinical
- Clinical I
- Clinical II
- Clinical III
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and clinical laboratories
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostics Centers
- Government/Non-profit Centers
- Academic and research institutes
- Others (CROs/CMOs)
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Illumina Inc
- Miltenyi Biotec
- QIAGEN
- Exosome Diagnostics
- Lonza Group
- Sysmex Corporation
- StellaLife Inc
- Cell Guidance Systems
- Bio-Techne Corporation
- Nanosomix
- Roche
- Cytiva
- Nanovision Biosciences
- Luminex Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Exosome Research Market, By Product Type
- Global Exosome Research Market, By Application
- Global Exosome Research Market, By Disease Indication
- Global Exosome Research Market, By Workflow
- Global Exosome Research Market, By Development Stage
- Global Exosome Research Market, By End User
- Global Exosome Research Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Exosome Research Market, By Product Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Consumables (kits, reagents, columns, beads, cartridges)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Instruments (e.g., NTA devices, microfluidic devices, Western blot, ELISA instruments)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Exosome Research Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diagnostics (e.g., cancer biomarker detection, neurological disease diagnostics, liquid biopsy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Therapeutics (e.g., drug delivery systems, regenerative medicine, vaccine development)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research and Development (basic research, drug discovery, disease mechanism studies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Exosome Research Market, By Disease Indication, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Neurology/neurodegeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Metabolic/endocrine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Autoimmune/inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Reproductive/prenatal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (e.g., dermatology, ophthalmology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Exosome Research Market, By Workflow, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Isolation Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ultracentrifugation
- Precipitation
- Immunoaffinity Capture
- Size-Based Isolation
- Microfluidic Techniques
- Downstream Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Characterization (Particle Size, Concentration, Surface Markers)
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
8. Global Exosome Research Market, By Development Stage, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Preclinical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Exosome Research Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and clinical laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hospitals and Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Government/Non-profit Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Exosome Research Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exosome Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- StellaLife Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Guidance Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanosomix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cytiva
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanovision Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us
